1 year return (CAGR)
-8.75%
Cassava Sciences Inc Exchange (NASDAQ, USD)
SAVA
1.21
+0.09 (+6.18%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-60.30%
5 year return (CAGR)
-50.18%
10 year return (CAGR)
-22.12%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
70.53M
Price/Sales
83.96
Ent value
18.98M
Price/Book
-
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 1.36 |
| Daily high | 1.47 |
| Daily low | 1.35 |
| Daily Volume | 476K |
| All-time high | 161.00 |
| 1y analyst estimate | 8.00 |
| Beta | -0.84 |
| EPS (TTM) | -1.61 |
| Dividend per share | 0.00 |
| Ex-div date | 13 Dec 2012 |
| Next earnings date | 3 Mar 2026 |
Downside potential
Loading...
Downside potential data
| SAVA | S&P500 | |
| Current price drop from All-time high | -99.25% | -0.15% |
| Highest price drop | -99.52% | -56.47% |
| Date of highest drop | 24 Dec 2018 | 9 Mar 2009 |
| Avg drop from high | -79.17% | -10.69% |
| Avg time to new high | 1622 days | 12 days |
| Max time to new high | 6451 days | 1805 days |
News
No items found